Internet of Events Leaderboard Traders Markets Hot Bets Surveillance Pricing

Log in Get Access

Accrue
/Home
/Manifold Markets
/Will Lecanemab be approved for Alzheimer's in Germany?

ManifoldResolved: NOBINARY · cpmm-1

Will Lecanemab be approved for Alzheimer's in Germany?

Yes6%

Yes Pool

$418

No Pool

$70

Resolution

NO

Probability

6%

Volume$360

24h Volume$0

Liquidity$130

Traders5

CreatorEli but Chad

ClosesDec 31, 2023

View on Manifold →Compare Across Platforms →

Accrue© 2026

Internet of Events Leaderboard Traders Markets Hot Bets Surveillance

The Intelligence Terminal for Prediction Markets

Terms Privacy Risk Disclosure Cookies Disclaimer Acceptable Use